Evaluating the effects and outcomes of COVID-19 infection in cancer patients:
In this week's CLL Society Tuesday Alert, Dr. Alan Skarbnik shared that while China, and Barcelona, Spain yield data, and our author himself, has looked into the possible efficacy of BTK inhibitors lessening the effects of COVID-19, the full picture which might adequately address cancer patients’ worries remains incomplete. Nevertheless, we urge you to read Dr. Skarbnik’s interesting article to keep in the know with what is being analyzed. Read here: bit.ly/2MB6jJ2